Why Wall Street and Jim Cramer think Danaher stock is ‘ready to go for a romp’
Danaher is finally turning the corner. CNBC’s Jim Cramer sees it. Wall Street does, too. The life sciences stock is “ready to go for a romp” after years of “nightmare” performance, Cramer said during Friday’s December Monthly Meeting for Investing Club members. Danaher — which makes tools and technologies used Continue Reading
FDA approved Singapore work trip during government shutdown, records show
SINGAPORE — Sentosa Island boasts the luxury, five-star Ora and Michael hotels, with palm-tree-lined pools, lobbies flanked with luxury stores, and a casino that adjoins both hotels and buzzes with gamblers. The Singapore resort is also where a group of federal employees from the U.S. Food and Drug Administration were Continue Reading
FDA may add strongest safety warning to Covid shots
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Food and Drug Administration may add its strongest safety warning to Covid shots – marking another major shift in vaccine oversight. Continue Reading
Food brands chase fibermaxxing trend with new high-fiber products
Cases of Pepsi soda are displayed at a Costco Wholesale store on Nov. 13, 2025 in Simi Valley, California. Kevin Carter | Getty Images One of this year’s top food trends is facing some tough competition. Protein captivated consumers and food companies in 2025, but fiber is increasingly stealing the Continue Reading
Zealand Pharma unveils 2030 plan as weight loss competition heats up
Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Continue Reading
Eli Lilly’s weight loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Thursday said its next-generation obesity drug delivered strong weight loss and reduced knee arthritis pain in a late-stage study, clearing the first of several upcoming trials Continue Reading
Eli Lilly to build $6 billion Alabama manufacturing plant
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion biomanufacturing plant in north Houston. (Raquel Natalicchio/Houston Chronicle via Getty Images) Raquel Natalicchio | Houston Chronicle | Getty Images Eli Lilly on Continue Reading
A biotech stock for investors scared to invest in the risky industry
Citigroup thinks investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the biotech stock at a buy rating and price target of $270, implying upside of 46% from Ligand’s Monday closing price of $184.67. Shares have soared nearly 79% this year. LGND Continue Reading
Pfizer strikes deal with YaoPharma for obesity pill
Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys | Reuters Pfizer on Tuesday Continue Reading
FDA approves Merck drug for decimated cattle herds to stop screwworm
Cattle detained in the pens of the Chihuahua Regional Livestock Union , at the Jeronimo-Santa Teresa border crossing in Ciudad Juarez, Mexico on November 27, 2024, after the United States stopped imports of Mexican cattle due to the presence of screwworm. Anadolu | Anadolu | Getty Images U.S. cattle ranchers Continue Reading